Biologics Market 2022 - By Type (Therapeutic Proteins, Monoclonal Antibodies ((MAbS), Vaccines), By Route Of Administration (Oral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription Drugs, Over-The-Counter (OTC) Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 393 | Published : January 2022 | | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Biologics Market Definition

The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics or biosimilars to treat and prevent various microbial diseases and cancers. The biologics market comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics.

Biologics products are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy, and marketing. Biologics products are isolated from natural sources such as human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies.

Biologics Market Size

The global biologics market reached a value of nearly $253,414.8 million in 2020, having increased at a compound annual growth rate (CAGR) of 8.7% since 2015. The market is expected to grow from $253,414.8 million in 2020 to $420,551.5 million in 2025 at a rate of 10.7%. The market is then expected to grow at a CAGR of 9.6% from 2025 and reach $664,744.2 million in 2030.  

Growth in the historic period resulted from aging population, government initiatives, ability to command high prices, and increased need for immunology. The market was restrained by pricing pressure from regulators, and lack of awareness on biosimilars among primary care physicians and specialists.

Going forward increase in funding, technological advancements, increase in healthcare access, robust research and development activities for development of oral biologics, lean towards pills over injections, and increasing robust pipeline of biologics will drive the growth. Factors that could hinder the growth of the biologics market in the future include high stringency and low turnover for clinical trials, stringent regulations related to biosimilar approvals, prolonged production and approval time, and nomenclature challenges.

Biologics Market Drivers

The key drivers of the biologics market included:

Increase In funding

Increasing funding from public and private organizations for the development of vaccines against COVID-19 is expected to drive the market in the forecast period. The large amount of funding from the public and private organizations accelerates the process of drug development and supports research of new drugs. For instance, In 2020, MTF Biologics which is a global non-profit organization has awarded over $1 million in funding to 11 research studies across the US through its 2020 Extramural Research Grants Program. Wellcome Trust, a UK based research -charity and the Gates Foundation announced collaboration with the credit card company MasterCard in a $125 million push to speed up development of drugs and vaccines for treating COVID-19 infections. Also, the Bill & Melinda Gates Foundation committed around $200 billion for the development of vaccines for different diseases. Hence increasing public-private funding for life science research will enhance the research and development which will drive the growth of the biologics market.

Biologics Market Restraints

The key restraints on the biologics market include:

High Stringency And Low Turnover For Clinical Trials

For pharmaceutical drugs, clinical studies such as the pharmacokinetics - pharmacodynamics (PK-PD) studies can be carried out on healthy individuals, if it can be safely administered to the healthy population. PK studies determine the time the drug takes to get absorbed, distributed, metabolized, and excreted within the body, and PD studies determine the biochemical and physiological effect of the drug. However, for biological drugs, there are some key considerations regarding the selection of healthy individuals. This is mainly because healthy individuals may have a higher immunogenic response than the population with the disease, and sometimes the PK of the reference product is altered when administered to a healthy individual. This results in unreliable clinical data. Such hindrances may stall the progress of biological drugs development.

Biologics Market Trends

Major trends shaping the biologics market include the following –

Revised FDA Regulations To Facilitate Biologics Drug Development

The US Food and Drug Administration (FDA) has revised its regulations to eliminate outdated biologics requirements, thus allowing drug manufacturers to employ new manufacturing technologies and testing capabilities. Standard preparations (standard solutions containing a precisely known concentration of an element), which help to ensure safety, purity and potency of biologics, can now be obtained from sources other than the FDA’s Center for Biologics Evaluation and Research (CBER), or can be developed internally by the biologics license applicant. The FDA has also removed a rule (Section 610.21 of FDA code) which specifies minimal potency limits to be met for certain antibodies and antigens. In addition, the FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics. These amendments in regulations are expected to increase regulatory flexibility by allowing the pharmaceutical industry and the FDA to incorporate current scientific technologies in the manufacture of licensed biological products. The number of new drug approvals was 48 in 2019, and increased to 53 in 2020. The new biologic product approvals in 2019 were 10 and as of October 2020 new biologic product approvals were 9.

Higher Profit Margins For Biologics

Companies in the biologics market are generating high profit margins due to high prices of biologics and their effectiveness. According to Statista, the profit margin in Q2 2020 for a few of the US biologics companies are 99.22% for Bluebird Bio Inc., 88.83% for Biogen, 86.82% for Asterias Biotherapeutics, and 82.71% for Allergan. Biologics treatment being nearly 22 times costlier than small molecule, is expected to generate a higher profit margin of around 40% in the future. For instance, the Biologics segment of Biocon Limited, an India-based biopharmaceutical company, reported 29% profit margins in the third quarter of FY 2019-2020.

Opportunities And Recommendations In Biologics Market

Opportunities –The top opportunities in the biologics market segmented by type will arise in the monoclonal antibodies segment, which will gain $75,160.9 million of global annual sales by 2025. The top opportunities in the monoclonal antibodies market segmented by type will arise in the anti-cancer mabs segment, which will gain $40,412.7 million of global annual sales by 2025. The top opportunities in the therapeutic proteins market segmented by type will arise in the metabolic disorders therapeutic proteins segment, which will gain $23,961.4 million of global annual sales by 2025. The top opportunities in the vaccines market segmented by type will arise in the anti-infective vaccines segment, which will gain $13,307.5 million of global annual sales by 2025. The top opportunities in the biologics market segmented by route of administration will arise in the others segment, which will gain $164,888.7 million of global annual sales by 2025. The top opportunities in the biologics market segmented by drug classification will arise in the branded drugs segment, which will gain $130,303.2 million of global annual sales by 2025.The top opportunities in the biologics market segmented by mode of purchase will arise in the prescription drugs segment, which will gain $129,786.1 million of global annual sales by 2025. The top opportunities in the biologics market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $79,943.8 million of global annual sales by 2025. The biologics market size will gain the most in the USA at $84,453.4 million.

Recommendations-To take advantage of the opportunities, the business research company recommends the biologics companies to focus on research & development, use of large molecules, focus on drug development for complex diseases, expand in emerging markets, set up authorized distributors and sales representatives, leverage online pharmacies, targeting local pharmacies to spread awareness, provide competitively priced offerings in low-income countries to reach new users, skimmed pricing for innovative drugs, direct-to-customer (DTC) advertising, participate in trade shows and events, increased requirement of R&D scientists.

Biologics Market Segmentation

The biologics market is segmented by type, by rote of administration, by drug classification, by mode of purchase and by distribution channel.
By Type-
The biologics market is segmented by type into
a. Therapeutic Proteins
    • 1) Metabolic Disorders Therapeutic Proteins
    • 2) Cancer Therapeutic Proteins
    • 3) Cardiovascular Therapeutic Proteins
    • 4) Immunological Therapeutic Proteins
    • 5) Other Therapeutic Proteins

b. Monoclonal Antibodies (MAbS)
    • 1) Anti-Cancer MAbs
    • 2) Immunological MAbS
    • 3) Anti-Infective Monoclonal Antibodies (MAbs)
    • 4) Neuropharmacological MAbs
    • 5) Cardiovascular And Cerebrovascular MAbS
    • 6) Others - Monoclonal Antibodies (MAbs)

c. Vaccines
    • 1) Anti-Infective Vaccines
    • 2) Autoimmunity Vaccines
    • 3) Others-Vaccines
The monoclonal antibodies market was the largest segment of the biologics market segmented by type, accounting for 42.8% of the total in 2020. Going forward, the monoclonal antibodies segment is expected to be the fastest growing segment in the biologics market segmented by type, at a CAGR of 11.1% during 2020-2025.
By Route Of Administration –
The biologics market is segmented by route of administration into
    • a. Oral
    • b. Others (IV and IP)
The others market was the largest segment of the biologics market segmented by route of administration, accounting for 98.5% of the total in 2020. Going forward, the others segment is expected to be the fastest growing segment in the biologics market segmented by route of administration, at a CAGR of 10.7% during 2020-2025.
By Drug Classification –
The biologics market is segmented by drug classification into
    • a. Branded Drugs
    • b. Generic Drugs
The branded drugs market was the largest segment of the biologics market segmented by drug classification, accounting for 80.0% of the total in 2020. Going forward, the generic drugs segment is expected to be the fastest growing segment in the biologics market segmented by drug classification, at a CAGR of 11.6% during 2020-2025.
By Mode Of Purchase –
The biologics market is segmented by mode of purchase into
    • a. Prescription Drugs
    • b. Over-The-Counter (OTC) Drugs
The prescription drugs market was the largest segment of the biologics market segmented by mode of purchase, accounting for 78.2% of the total in 2020. Going forward, the OTC drugs segment is expected to be the fastest growing segment in the biologics market segmented by mode of purchase, at a CAGR of 10.9% during 2020-2025.
By Distribution Channel –
The biologics market is segmented by application into
    • a. Hospital Pharmacies
    • b. Retail Pharmacies
    • c. Online Pharmacies
The hospital pharmacies market was the largest segment of the biologics market segmented by hospital pharmacies, accounting for 50.1% of the total in 2020. Going forward, the online pharmacies segment is expected to be the fastest growing segment in the biologics market segmented by distribution channel, at a CAGR of 16.4% during 2020-2025.
By Geography -
The biologics market is segment by geography into
    • o North America
      • • USA
      • • Canada
      • • Mexico
      • o Western Europe,
      • • UK
      • • Germany
      • • France
      • • Italy
      • • Spain
      • • Austria
      • • Belgium
      • • Denmark
      • • Finland
      • • Ireland
      • • Netherlands
      • • Norway
      • • Portugal
      • • Sweden
      • • Switzerland
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      • • Hong Kong
      • • Malaysia
      • • New Zealand
      • • Philippines
      • • Singapore
      • • Thailand
      • • Vietnam
      o Eastern Europe
      • • Russia
      • • Czech Republic
      • • Poland
      • • Romania
      o South America
      • • Brazil
      • • Argentina
      • • Chile
      • • Colombia
      • • Peru
      • • Venezuela
      o Middle East
      • • Israel
      • • Saudi Arabia
      • • Turkey
      • • UAE
      o Africa
      • • Egypt
      • • Nigeria
      • • South Africa
North America was the largest region in the global biologics market, accounting for 53.2% of the total in 2020. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the biologics market will be South America and Asia-Pacific, where growth will be at CAGRs of 14.8% and 11.4% respectively during 2020-2025. These will be followed by Eastern Europe and Africa where the markets are expected to grow at CAGRs of 11.4% and 11.3% respectively during 2020-2025.

Biologics Competitive Landscape

Major Competitors are:

  • Merck & Co., Inc.
  • AbbVie Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Pfizer Inc.

    • Other Competitors Include:

  • Bristol Myers Squibb Company
  • Sanofi S.A.
  • GlaxoSmithKline Plc.
  • Eli Lilly and Company
  • Amgen Inc.
  • Wockhardt
  • Zydus Cadilla
  • Asahi Glass Co. Ltd.
  • China Biologic Products Holdings Inc.
  • China Regenerative Medicine International
  • AstraZenaca
  • ABLbio
  • Adimmune
  • Henlius
  • Innovent Biologics
  • Bio-Thera
  • Hisun Pharma
  • 3SBio
  • Beijing ShuangLu Pharmaceuticals
  • Qilu Pharmaceutical
  • Shanghai Fosun Pharmaceuticals
  • Biocon
  • Dr.Reddy’s
  • Mylan
  • Kyowa Hakko Kirin
  • Takeda
  • Mitsubishi Tanabe
  • AGC Biologics
  • Eli Lilly and Company, Inc.
  • Sanofi
  • Amgen Inc
  • AbbVie Inc
  • Biogen Idec
  • Bayer AG
  • Johnson & Johnson Services
  • Pfizer, Inc.
  • Novartis AG
  • BiosanaPharma
  • WuXi
  • GlaxoSmithKline
  • Teva UK Limited
  • AstraZeneca
  • Abbott Laboratories
  • Vectura Group
  • Roche
  • Fujifilm
  • Lonza
  • Seqens
  • Piramal Pharma Solutions
  • Corden Pharma
  • Procos SpA
  • BSP Pharmaceuticals.
  • Microgen
  • Geropharm
  • Valenta
  • NovaMedica
  • SynBio
  • Rani Therapeutics
  • Emisphere Technologies, Inc.
  • Enteris BioPharma
  • Allena Pharmaceuticals
  • Abbvie
  • Biogen Inc
  • Hypermarcas
  • Aché
  • Eurofarma and Teuto Brasileiro
  • BioMarin Pharmaceutical
  • BIONOVIS BRASIL
  • Ecopharm
  • Julphar
  • SPIMACO ADDWAEIH
  • Hikma Pharmaceuticals
  • BBI Solutions
  • Aspen Pharmacare
  • Amoun Pharmaceuticals CO Ltd
  • 54gene
  • Baxter International
  • Altis Biologics
  • Cipla Medpro South Africa
  • Sanofi Genzyme

      • Table Of Contents

      1. Biologics Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Type

      6.2.1. Monoclonal Antibodies (MAbS) Segmentation By Type

      6.2.2. Therapeutic Proteins Segmentation By Type

      6.2.3. Vaccines Segmentation By Type

      6.3. Segmentation By Route Of Administration

      6.4. Segmentation By Drug Classification

      6.5. Segmentation By Mode Of Purchase

      6.6. Segmentation By Distribution Channel

      7. Biologics Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Type

      7.2.1. Therapeutic Proteins

      7.2.2. Monoclonal Antibodies ((MAbS)

      7.2.3. Vaccines

      7.3. Market Segmentation By Route Of Administration

      7.3.1. Oral

      7.3.2. Others (IV and IP)

      7.4. Market Segmentation By Drug Classification

      7.4.1. Branded Drugs

      7.4.2. Generic Drugs

      7.5. Market Segmentation By Mode Of Purchase

      7.5.1. Prescription Drugs

      7.5.2. Over-The-Counter (OTC) Drugs

      7.6. Market Segmentation By Distribution Channel

      7.6.1. Hospital Pharmacies

      7.6.2. Retail Pharmacies

      7.6.3. Online Pharmacies

      8. Biologics Market, Supply Chain Analysis

      8.1. Raw Material Suppliers

      8.2. Research and Development

      8.2.1. Clinical Studies

      8.2.2. Contract Research Organization (CRO)

      8.2.3. Approval

      8.3. Biologics Manufacturing

      8.3.1. Contract Manufacturing Organization (CMO)

      8.4. Distribution

      8.4.1. Wholesalers/Distributors

      8.4.2. Retailers

      8.4.3. End Users

      9. Biologics Market Product Analysis – Product Examples

      10. Biologics Market Customer Information

      10.1. Awareness Of The Patients For Biosimilars And Biologics

      10.2. Perception On The Adoption Of Biosimilars

      10.3. Patients’ Preference For Biosimilar Over Biologics

      10.4. Preference For Influenza Vaccines With Fewer Side Effects

      10.5. Hesitance Of Patients Towards Immunization Vaccines Due To Its Side Effects

      10.6. Patient Preference for Biologic treatments for Psoriasis

      10.7. Patients’ Preference for Biologics Over Biosimilar

      11. Biologics Market Trends And Strategies

      11.1. Revised FDA Regulations To Facilitate Biologics Drug Development

      11.2. Higher Profit Margins For Biologics

      11.3. Shift From Small Molecules To Biologics

      11.4. Robust Research & Development

      11.5. Demand For Biologics In The Treatment Of Complex Diseases

      11.6. Single Use-Technologies For Cost-Effective Production

      12. Impact Of Covid-19 On Biologics Market

      12.1. Impact On R&D Funding

      12.2. Impact On Supply Chain

      12.3. Recovery

      13. Global Biologics Market Size And Growth

      13.1. Market Size

      13.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.2.1. Drivers Of The Market 2015 – 2020

      13.2.2. Restraints On The Market 2015 – 2020

      13.3. Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.3.1. Drivers Of The Market 2020 – 2025

      13.3.2. Restraints On The Market 2020 – 2025

      14. Biologics Market, Regional Analysis

      14.1. Global Biologics Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.2. Global Biologics Market, 2015 – 2025, Historic And Forecast, By Region

      14.3. Global Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Region

      15. Global Biologics Market Segmentation

      15.1. Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.1.1. Monoclonal Antibodies

      15.1.2. Therapeutic Proteins

      15.1.3. Vaccines

      15.1.4. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.1.5. Anti-Cancer MAbS

      15.1.6. Immunological MAbS

      15.1.7. Anti-Infective Monoclonal Antibodies (MAbS)

      15.1.8. Others - Monoclonal Antibodies (MAbs)

      15.1.9. Cardiovascular And Cerebrovascular MAbS

      15.1.10. Neuropharmacological MABS

      15.1.11. The global monoclonal antibodies

      15.1.12. Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.1.13. Metabolic Disorders Therapeutic Proteins

      15.1.14. Cancer Therapeutic Proteins

      15.1.15. Others - Therapeutic Proteins

      15.1.16. Cardiovascular Therapeutic Proteins

      15.1.17. Immunological Therapeutic Proteins

      15.1.18. Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.1.19. Anti-Infective Vaccines

      15.1.20. Autoimmunity Vaccines

      15.1.21. Others-Vaccines

      15.2. Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.2.1. Others

      15.2.2. Oral

      15.3. Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.3.1. Branded Drugs

      15.3.2. Generic Drugs

      15.4. Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.4.1. Prescription Drugs

      15.4.2. OTC Drugs

      15.5. Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5.1. Hospital Pharmacies

      15.5.2. Retail Pharmacies

      15.5.3. Online Pharmacies

      16. Global Biologics Market Comparison with Macro Economic Factors

      16.1. Biologics Market Size, Percentage Of GDP, Global

      16.2. Per Capita Average Biologics Market Expenditure, Global

      17. Asia-Pacific Biologics Market

      17.1. Asia-Pacific Biologics Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Impact Of COVID-19

      17.1.4. Background Information

      17.1.5. Government Initiatives

      17.1.6. Regulations

      17.1.7. Regulatory Bodies

      17.1.8. Major Associations

      17.1.9. Taxes Levied

      17.1.10. Corporate Tax Structure

      17.1.11. Investments

      17.1.12. Major Companies

      17.2. Asia-Pacific Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. Asia-Pacific Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.4. Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. Asia-Pacific Biologics Market, 2019, By Country, Value ($ Million)

      17.6. Asia-Pacific Biologics Market, 2015 – 2025, Historic And Forecast, By Country

      17.7. Asia-Pacific Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      17.8. Asia-Pacific Biologics Market Metrics

      17.8.1. Per Capita Biologics Expenditure, 2020, Asia-Pacific Major Countries

      17.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Asia-Pacific Countries

      17.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Asia-Pacific Countries

      17.9. Asia-Pacific Biologics Market: Country Analysis

      17.10. Australia Biologics Market

      17.11. Australia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.12. Australia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.13. Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Billion)

      17.14. China Biologics Market

      17.15. China Biologics Market Overview

      17.15.1. Country Information

      17.15.2. Market Information

      17.15.3. Impact Of COVID-19

      17.15.4. Background Information

      17.15.5. Government Initiatives

      17.15.6. Regulations

      17.15.7. Regulatory Bodies

      17.15.8. Major Associations

      17.15.9. Taxes Levied

      17.15.10. Corporate Tax Structure

      17.15.11. Investments

      17.15.12. Major Companies

      17.16. China Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.17. China Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.18. China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Billion)

      17.19. Hong Kong Biologics Market

      17.20. Hong Kong Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.21. Hong Kong Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.22. India Biologics Market

      17.23. India Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.24. India Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.25. India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Billion)

      17.26. Indonesia Biologics Market

      17.27. Indonesia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.28. Indonesia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.29. Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Billion)

      17.30. Japan Biologics Market

      17.31. Japan Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.32. Japan Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.33. Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Billion)

      17.34. Malaysia Biologics Market

      17.35. Malaysia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.36. Malaysia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.37. New Zealand Biologics Market

      17.38. New Zealand Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.39. New Zealand Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.40. Philippines Biologics Market

      17.41. Philippines Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.42. Philippines Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.43. Singapore Biologics Market

      17.44. Singapore Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.45. Singapore Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.46. South Korea Biologics Market

      17.47. South Korea Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.48. South Korea Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.49. South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.50. Thailand Biologics Market

      17.51. Thailand Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.52. Thailand Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.53. Vietnam Biologics Market

      17.54. Vietnam Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.55. Vietnam Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18. Western Europe Biologics Market

      18.1. Western Europe Biologics Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. COVID Impact

      18.1.4. Background Information

      18.1.5. Government Initiatives

      18.1.6. Regulations

      18.1.7. Regulatory Bodies

      18.1.8. Major Associations

      18.1.9. Taxes Levied

      18.1.10. Corporate Tax Structure

      18.1.11. Investments

      18.1.12. Major Companies

      18.2. Western Europe Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3. Western Europe Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.4. Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Western Europe Biologics Market, 2020, By Country, Value ($ Million)

      18.6. Western Europe Biologics Market, 2015 – 2025, Historic And Forecast, By Country

      18.7. Western Europe Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      18.8. Western Europe Biologics Market Metrics

      18.8.1. Per Capita Biologics Expenditure, 2020, Western Europe Major Countries

      18.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Western Europe Countries

      18.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Western Europe Countries

      18.9. Western Europe Biologics Market: Country Analysis

      18.10. Austria Biologics Market

      18.11. Austria Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.12. Austria Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.13. Belgium Biologics Market

      18.14. Belgium Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.15. Belgium Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.16. Denmark Biologics Market

      18.17. Denmark Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.18. Denmark Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.19. Finland Biologics Market

      18.20. Finland Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.21. Finland Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.22. France Biologics Market

      18.23. France Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.24. France Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.25. France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.26. Germany Biologics Market

      18.27. Germany Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.28. Germany Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.29. Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.30. Ireland Biologics Market

      18.31. Ireland Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.32. Ireland Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.33. Italy Biologics Market

      18.34. Italy Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.35. Italy Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.36. Netherlands Biologics Market

      18.37. Netherlands Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.38. Netherlands Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.39. Norway Biologics Market

      18.40. Norway Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.41. Norway Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.42. Portugal Biologics Market

      18.43. Portugal Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.44. Portugal Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.45. Spain Biologics Market

      18.46. Spain Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.47. Spain Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.48. Sweden Biologics Market

      18.49. Sweden Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.50. Sweden Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.51. Switzerland Biologics Market

      18.52. Switzerland Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.53. Switzerland Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.54. UK Biologics Market

      18.55. UK Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.56. UK Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.57. UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Eastern Europe Biologics Market

      19.1. Eastern Europe Biologics Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes Levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Eastern Europe Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3. Eastern Europe Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      19.4. Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Eastern Europe Biologics Market, 2020, By Country, Value ($ Million)

      19.6. Eastern Europe Biologics Market, 2015 – 2025, Historic And Forecast, By Country

      19.7. Eastern Europe Biologics Market Metrics

      19.7.1. Per Capita Biologics Expenditure, 2020, Eastern Europe Major Countries

      19.7.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Eastern Europe Countries

      19.7.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Eastern Europe Countries

      19.8. Eastern Europe Biologics Market: Country Analysis

      19.9. Czech Republic Biologics Market

      19.10. Czech Republic Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.11. Czech Republic Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      19.12. Poland Biologics Market

      19.13. Poland Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.14. Poland Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      19.15. Romania Biologics Market

      19.16. Romania Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.17. Romania Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      19.18. Russia Biologics Market

      19.19. Russia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.20. Russia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      19.21. Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. North America Biologics Market

      20.1. North America Biologics Market Overview

      20.1.1. Region Information

      20.1.2. Market Information

      20.1.3. Impact Of COVID-19

      20.1.4. Background Information

      20.1.5. Government Initiatives

      20.1.6. Regulations

      20.1.7. Regulatory Bodies

      20.1.8. Major Associations

      20.1.9. Taxes Levied

      20.1.10. Corporate Tax Structure

      20.1.11. Investment

      20.1.12. Major Companies

      20.2. North America Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.3. North America Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      20.4. North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20.5. North America Biologics Market, 2020, By Country, Value ($ Million)

      20.6. North America Biologics Market, 2015 – 2025, Historic And Forecast, By Country

      20.7. North America Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      20.8. North America Biologics Market Metrics

      20.8.1. Per Capita Biologics Expenditure, 2020, North America Major Countries

      20.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, North America Countries

      20.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, North America Countries

      20.9. North America Biologics Market: Country Analysis

      20.10. Canada Biologics Market

      20.11. Canada Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.12. Canada Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      20.13. Mexico Biologics Market

      20.14. Mexico Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.15. Mexico Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      20.16. USA Biologics Market

      20.17. USA Biologics Market Overview

      20.17.1. Country Information

      20.17.2. Market Information

      20.17.3. COVID Impact

      20.17.4. Background Information

      20.17.5. Government Initiatives

      20.17.6. Regulations

      20.17.7. Regulatory Bodies

      20.17.8. Major Associations

      20.17.9. Taxes Levied

      20.17.10. Corporate Tax Structure

      20.17.11. Investments

      20.17.12. Major Companies

      20.18. USA Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.19. USA Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      20.20. USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      21. South America Biologics Market

      21.1. South America Biologics Market Overview

      21.1.1. Region Information

      21.1.2. Market Information

      21.1.3. COVID Impact

      21.1.4. Background Information

      21.1.5. Government Initiatives

      21.1.6. Regulations

      21.1.7. Regulatory Bodies

      21.1.8. Major Associations

      21.1.9. Taxes Levied

      21.1.10. Corporate Tax Structure

      21.1.11. Investments

      21.1.12. Major Companies

      21.2. South America Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.3. South America Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      21.4. South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      21.5. South America Biologics Market, 2020, By Country, Value ($ Million)

      21.6. South America Biologics Market, 2015 – 2025, Historic And Forecast, By Country

      21.7. South America Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      21.8. South America Biologics Market Metrics

      21.8.1. Per Capita Biologics Expenditure, 2020, South America Major Countries

      21.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, South America Countries

      21.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, South America Countries

      21.9. South America Biologics Market: Country Analysis

      21.10. Argentina Biologics Market

      21.11. Argentina Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.12. Argentina Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      21.13. Brazil Biologics Market

      21.14. Brazil Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.15. Brazil Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      21.16. Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      21.17. Chile Biologics Market

      21.18. Chile Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.19. Chile Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      21.20. Colombia Biologics Market

      21.21. Colombia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.22. Colombia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      21.23. Peru Biologics Market

      21.24. Peru Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.25. Peru Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      21.26. Venezuela Biologics Market

      21.27. Venezuela Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.28. Venezuela Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      22. Middle East Biologics Market

      22.1. Middle East Biologics Market Overview

      22.1.1. Region Information

      22.1.2. Market Information

      22.1.3. Impact Of COVID-19

      22.1.4. Background Information

      22.1.5. Government Initiatives

      22.1.6. Regulations

      22.1.7. Regulatory Bodies

      22.1.8. Major Associations

      22.1.9. Taxes Levied

      22.1.10. Corporate Tax Structure

      22.1.11. Investments

      22.1.12. Major Companies

      22.2. Middle East Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.3. Middle East Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      22.4. Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      22.5. Middle East Biologics Market, 2020, By Country, Value ($ Million)

      22.6. Middle East Biologics Market, 2015 – 2025, Historic And Forecast, By Country

      22.7. Middle East Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      22.8. Middle East Biologics Market Metrics

      22.8.1. Per Capita Biologics Expenditure, 2020, Middle East Major Countries

      22.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Middle East Countries

      22.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Middle East Countries

      22.9. Middle East Biologics Market: Country Analysis

      22.10. Israel Biologics Market

      22.11. Israel Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.12. Israel Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      22.13. Saudi Arabia Biologics Market

      22.14. Saudi Arabia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.15. Saudi Arabia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      22.16. Turkey Biologics Market

      22.17. Turkey Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.18. Turkey Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      22.19. UAE Biologics Market

      22.20. UAE Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.21. UAE Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      23. Africa Biologics Market

      23.1. Africa Biologics Market Overview

      23.1.1. Region Information

      23.1.2. Market Information

      23.1.3. Impact Of COVID-19

      23.1.4. Background Information

      23.1.5. Government Initiatives

      23.1.6. Regulations

      23.1.7. Regulatory Bodies

      23.1.8. Major Associations

      23.1.9. Taxes Levied

      23.1.10. Corporate Tax Structure

      23.1.11. Investments

      23.1.12. Major Companies

      23.2. Africa Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.3. Africa Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      23.4. Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      23.5. Africa Biologics Market, 2020, By Country, Value ($ Million)

      23.6. Africa Biologics Market, 2015 – 2025, Historic And Forecast, By Country

      23.7. Africa Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      23.8. Africa Biologics Market Metrics

      23.8.1. Per Capita Biologics Expenditure, 2020, Africa Major Countries

      23.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Africa Countries

      23.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Africa Countries

      23.9. Africa Biologics Market: Country Analysis

      23.10. Egypt Biologics Market

      23.11. Egypt Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.12. Egypt Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      23.13. Nigeria Biologics Market

      23.14. Nigeria Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.15. Nigeria Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      23.16. South Africa Biologics Market

      23.17. South Africa Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.18. South Africa Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      24. Global Biologics Market Competitive Landscape

      24.1. Company Profiles

      24.2. Merck & Co., Inc., Inc.

      24.2.1. Company Overview

      24.2.2. Products And Services

      24.2.3. Business Strategy

      24.2.4. Financial Overview

      24.3. AbbVie Inc.

      24.3.1. Company Overview

      24.3.2. Products And Services

      24.3.3. Business Strategy

      24.3.4. Financial Overview

      24.4. F. Hoffmann-La Roche AG

      24.4.1. Company Overview

      24.4.2. Products And Services

      24.4.3. Business Strategy

      24.4.4. Financial Overview

      24.5. Johnson & Johnson

      24.5.1. Company Overview

      24.5.2. Products And Services

      24.5.3. Business Strategy

      24.5.4. Financial Overview

      24.6. Pfizer Inc.

      24.6.1. Company Overview

      24.6.2. Products And Services

      24.6.3. Business Strategy

      24.6.4. Financial Overview

      25. Key Mergers And Acquisitions In The Biologics Market

      25.1. Boehringer Ingelheim Acquired Preclinical Antibody Pipeline From Northern Biologics Inc.

      25.2. Abbvie Acquired Allergan

      25.3. QuestCap Inc. Acquired 40% Shares In Amino Therapeutics Inc.

      25.4. WuXi Biologics Acquired Drug Product Manufacturing Plant From Bayer

      25.5. Takeda Pharmaceutical Company Acquired PvP Biologics, Inc.

      25.6. True North Acquired Stake In Biocon Biologics

      25.7. Catalent, Inc. Acquired Bristol Myers Squibb’s Oral Dose Manufacturing Facility

      25.8. Bristol Myers Acquired Celgene

      25.9. Evotec Acquired Just Biotherapeutics

      25.10. AstraZeneca Strikes Stock Deal With Daiichi Sankyo

      25.11. Boehringer Acquires Rights To ICD Therapeutics And Its Biologics-Delivery Platform

      25.12. Catalent, Inc. Acquired Cook Pharmica LLC

      26. Market Background: Pharmaceuticals Market

      26.1. Pharmaceuticals Market Characteristics

      26.1.1. Market Definition

      26.1.2. Segmentation By Type

      26.2. Global Pharmaceuticals Market, Segmentation By Type, 2015 – 2025, Value ($ Billion)

      26.3. Global Pharmaceuticals Market, 2020, By Region, Value ($ Billion)

      26.4. Global Pharmaceuticals Market, 2015 – 2025, Historic And Forecast, By Region

      27. Biologics Market Opportunities And Strategies

      27.1. Global Biologics Market In 2025 – Countries Offering Most New Opportunities

      27.2. Global Biologics Market In 2025 – Segments Offering Most New Opportunities

      27.3. Global Biologics Market In 2025 – Growth Strategies

      27.3.1. Market Trend Based Strategies

      27.3.2. Competitor Strategies

      28. Biologics Market, Conclusions And Recommendations

      28.1. Conclusions

      28.2. Recommendations

      28.2.1. Product

      28.2.2. Place

      28.2.3. Price

      28.2.4. Promotion

      28.2.5. People

      29. Appendix

      29.1. Market Data Sources

      29.2. Research Methodology

      29.3. Currencies

      29.4. Research Inquiries

      29.5. The Business Research Company

      29.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Biologics Market, Product Analysis – Product Examples
    • Table 2: Global Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 3: Global Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 4: Global Biologics Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 5: Global Biologics Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 6: Global Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Table 7: Global Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Region
    • Table 8: Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 9: Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 10: Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 11: Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 12: Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 13: Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 14: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 15: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 16: Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 17: Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 18: Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 19: Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 20: Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 21: Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 22: Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 23: Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 24: Global Biologics Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2025
    • Table 25: Global Biologics Market, Per Capita Average Biologics Market Industry Expenditure, 2015 – 2025, ($)
    • Table 26: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 27: Asia-Pacific Biologics Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 28: Asia-Pacific, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 29: Asia Pacific Pharmaceuticals drugs Market Size, 2015-2025, $ Billion
    • Table 30: Asia-Pacific Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 31: Asia-Pacific Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 32: Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 33: Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 34: Asia-Pacific Biologics Market, 2020, By Country, Value ($ Million)
    • Table 35: Asia-Pacific Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 36: Asia-Pacific Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 37: Asia-Pacific Per Capita Biologics Expenditure, By Country, 2020, $
    • Table 38: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2020, Asia-Pacific Countries
    • Table 39: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2020, Asia-Pacific Countries
    • Table 40: Australia Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 41: Australia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 42: Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 43: Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Billion
    • Table 44: China GDP Per Capita, 2015-2020, $
    • Table 45: China Biologics Market, Population By Age Group, 2015-2025, Thousands
    • Table 46: China Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 47: China Pharmaceuticals Drugs Market Size, 2015-2025, $ Billion
    • Table 48: China Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 49: China Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 50: China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 51: China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Billion
    • Table 52: Hong Kong Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 53: Hong Kong Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 54: India Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 55: India Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 56: India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 57: India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Billion
    • Table 58: Indonesia Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 59: Indonesia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 60: Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 61: Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Billion
    • Table 62: Japan Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 63: Japan Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 64: Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 65: Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Billion
    • Table 66: Malaysia Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 67: Malaysia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 68: New Zealand Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 69: New Zealand Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 70: Philippines Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 71: Philippines Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 72: Singapore Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 73: Singapore Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 74: South Korea Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 75: South Korea Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 76: South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 77: South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 78: Thailand Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 79: Thailand Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 80: Vietnam Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 81: Vietnam Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 82: Western Europe GDP Per Capita, 2015-2020, $
    • Table 83: Western Europe Biologics Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 84: Western Europe, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 85: Western Europe Pharmaceuticals Drugs Market Size, 2015-2025, $ Billion
    • Table 86: Western Europe Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 87: Western Europe Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 88: Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 89: Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 90: Western Europe Biologics Market, 2020, By Country, Value ($ Million)
    • Table 91: Western Europe Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 92: Western Europe Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 93: Western Europe Per Capita Biologics Expenditure, By Country, 2020, $
    • Table 94: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2020, Western Europe Countries
    • Table 95: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2020, Western Europe Countries
    • Table 96: Austria Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 97: Austria Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 98: Belgium Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 99: Belgium Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 100: Denmark Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 101: Denmark Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 102: Finland Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 103: Finland Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 104: France Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 105: France Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 106: France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 107: France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 108: Germany Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 109: Germany Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 110: Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 111: Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 112: Ireland Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 113: Ireland Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 114: Italy Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 115: Italy Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 116: Netherlands Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 117: Netherlands Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 118: Norway Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 119: Norway Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 120: Portugal Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 121: Portugal Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 122: Spain Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 123: Spain Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 124: Sweden Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 125: Sweden Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 126: Switzerland Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 127: Switzerland Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 128: UK Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 129: UK Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 130: UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 131: UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 132: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 133: Eastern Europe Biologics Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 134: Eastern Europe, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 135: Eastern Europe Pharmaceuticals Drugs Market Size, 2015-2025, $ Billion
    • Table 136: Eastern Europe Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 137: Eastern Europe Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 138: Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 139: Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 140: Eastern Europe Biologics Market, 2020, By Country, Value ($ Million)
    • Table 141: Eastern Europe Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 142: Eastern Europe Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 143: Eastern Europe Per Capita Biologics Expenditure, By Country, 2020, $
    • Table 144: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2020, Eastern Europe Countries
    • Table 145: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2020, Eastern Europe Countries
    • Table 146: Czech Republic Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 147: Czech Republic Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 148: Poland Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 149: Poland Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 150: Romania Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 151: Romania Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 152: Russia Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 153: Russia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 154: Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 155: Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 156: North America GDP Per Capita, 2015-2020, $
    • Table 157: North America Biologics Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 158: North America, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 159: North America Pharmaceuticals Drugs Market Size, 2015-2025, $ Billion
    • Table 160: North America Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 161: North America Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 162: North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 163: North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 164: North America Biologics Market, 2020, By Country, Value ($ Million)
    • Table 165: North America Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 166: North America Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 167: North America Per Capita Biologics Expenditure, By Country, 2020, $
    • Table 168: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2020, North America Countries
    • Table 169: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2020, North America Countries
    • Table 170: Canada Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 171: Canada Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 172: Mexico Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 173: Mexico Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 174: USA GDP Per Capita, 2015-2020, $
    • Table 175: USA Biologics Market, Population By Age Group, 2015-2025, Thousands
    • Table 176: USA Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 177: USA Pharmaceuticals Drugs Market Size, 2015-2025, $ Billion
    • Table 178: USA Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 179: USA Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 180: USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 181: USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 182: South America GDP Per Capita, 2015-2020, $
    • Table 183: South America Biologics Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 184: South America, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 185: South America Pharmaceuticals Drugs Market Size, 2015-2025, $ Billion
    • Table 186: South America Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 187: South America Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 188: South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 189: South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 190: South America Biologics Market, 2020, By Country, Value ($ Million)
    • Table 191: South America Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 192: South America Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 193: South America Per Capita Biologics Expenditure, By Country, 2020, $
    • Table 194: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2020, South America Countries
    • Table 195: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2020, South America Countries
    • Table 196: Argentina Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 197: Argentina Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 198: Brazil Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 199: Brazil Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 200: Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 201: Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 202: Chile Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 203: Chile Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 204: Colombia Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 205: Colombia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 206: Peru Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 207: Peru Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 208: Venezuela Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 209: Venezuela Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 210: Middle East GDP Per Capita, 2015-2020, $
    • Table 211: Middle East Biologics Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 212: Middle East, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 213: Middle East Pharmaceuticals Drugs Market Size, 2015-2025, $ Billion
    • Table 214: Middle East Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 215: Middle East Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 216: Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 217: Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 218: Middle East Biologics Market, 2020, By Country, Value ($ Million)
    • Table 219: Middle East Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 220: Middle East Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 221: Middle East Per Capita Biologics Expenditure, By Country, 2020, $
    • Table 222: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2020, Middle East Countries
    • Table 223: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2020, Middle East Countries
    • Table 224: Israel Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 225: Israel Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 226: Saudi Arabia Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 227: Saudi Arabia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 228: Turkey Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 229: Turkey Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 230: UAE Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 231: UAE Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 232: Africa GDP Per Capita, 2015-2020, $
    • Table 233: Africa Biologics Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 234: Africa, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 235: Africa Pharmaceuticals Drugs Market Size, 2015-2025, $ Billion
    • Table 236: Africa Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 237: Africa Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 238: Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 239: Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 240: Africa Biologics Market, 2020, By Country, Value ($ Million)
    • Table 241: Africa Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 242: Africa Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 243: Africa Per Capita Biologics Expenditure, By Country, 2020, $
    • Table 244: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2020, Africa Countries
    • Table 245: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2020, Africa Countries
    • Table 246: Egypt Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 247: Egypt Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 248: Nigeria Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 249: Nigeria Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 250: South Africa Biologics Market, Historic, 2015 – 2020, $ Million
    • Table 251: South Africa Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 252: Global Biologics Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 253: Merck & Co., Inc. – Financial Performance, 2016-2020, $ Billion
    • Table 254: AbbVie Inc.– Financial Performance, 2016 - 2020, $ Billion
    • Table 255: F. Hoffmann-La Roche AG – Financial Performance, 2016 – 2020, $ Billion
    • Table 256: Johnson & Johnson – Financial Performance, 2016 – 2020, $ Billion
    • Table 257: Pfizer Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Table 258: Global Pharmaceuticals Market, Segmentation By Type, 2015 – 2025, $ Billion
    • Table 259: Global Pharmaceuticals Market, 2020, Split By Region
    • Table 260: Global Pharmaceuticals Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Table 261: Global Biologics Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 262: Global Biologics Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 263: Global Monoclonal Antibodies (MAbS) Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 264: Global Therapeutic Proteins Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 265: Global Vaccines Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 266: Global Biologics Market Size Gain ($ Million), Segmentation By Route Of Administration, 2020 – 2025
    • Table 267: Global Biologics Market Size Gain ($ Million), Segmentation By Drug Classification, 2020 – 2025
    • Table 268: Global Biologics Market Size Gain ($ Million), Segmentation By Mode Of Purchase, 2020 – 2025
    • Table 269: Global Biologics Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025
    • Table 270: Biologics Market - Data Sources

    List Of Figures

      Figure 1: Global Biologics Market Segmentation By Type
    • Figure 2: Global Monoclonal Antibodies (MAbS) Market Segmentation By Type
    • Figure 3: Global Therapeutic Proteins Market Segmentation By Type
    • Figure 4: Global Vaccines Market Segmentation By Type
    • Figure 5: Global Biologics Market Segmentation By Route Of Administration
    • Figure 6: Global Biologics Market Segmentation By Drug Classification
    • Figure 7: Global Biologics Market Segmentation By Mode Of Purchase
    • Figure 8: Global Biologics Market Segmentation By Distribution Channel
    • Figure 9: Biologics Industry, Supply Chain Analysis
    • Figure 10: Global Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 11: Global Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 12: Global Biologics Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 13: Global Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Figure 14: Global Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Region
    • Figure 15: Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 16: Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 17: Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 20: Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 21: Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Asia-Pacific Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Asia-Pacific Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Asia-Pacific Biologics Market, 2020, By Country, Value ($ Million)
    • Figure 27: Asia-Pacific Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 28: Asia-Pacific Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 29: Australia Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 30: Australia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 31: Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 32: China Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 33: China Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 34: China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: Hong Kong Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 36: Hong Kong Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 37: India Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 38: India Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 39: India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 40: Indonesia Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 41: Indonesia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 42: Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: Japan Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 44: Japan Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: Malaysia Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 47: Malaysia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 48: New Zealand Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 49: New Zealand Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 50: Philippines Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 51: Philippines Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 52: Singapore Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 53: Singapore Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 54: South Korea Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 55: South Korea Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 56: South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 57: Thailand Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 58: Thailand Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 59: Vietnam Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 60: Vietnam Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 61: Western Europe Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 62: Western Europe Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 63: Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 64: Western Europe Biologics Market, 2020, By Country, Value ($ Million)
    • Figure 65: Western Europe Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 66: Western Europe Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 67: Austria Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 68: Austria Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: Belgium Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 70: Belgium Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 71: Denmark Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 72: Denmark Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 73: Finland Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 74: Finland Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 75: France Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 76: France Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: Germany Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 79: Germany Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 80: Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 81: Ireland Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 82: Ireland Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 83: Italy Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 84: Italy Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 85: Netherlands Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 86: Netherlands Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 87: Norway Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 88: Norway Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 89: Portugal Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 90: Portugal Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 91: Spain Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 92: Spain Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 93: Sweden Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 94: Sweden Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 95: Switzerland Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 96: Switzerland Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 97: UK Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 98: UK Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 99: UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 100: Eastern Europe Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 101: Eastern Europe Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 102: Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 103: Eastern Europe Biologics Market, 2020, By Country, Value ($ Million)
    • Figure 104: Eastern Europe Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 105: Eastern Europe Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 106: Czech Republic Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 107: Czech Republic Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 108: Poland Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 109: Poland Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 110: Romania Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 111: Romania Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 112: Russia Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 113: Russia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 114: Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 115: North America Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 116: North America Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 117: North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 118: North America Biologics Market, 2020, By Country, Value ($ Million)
    • Figure 119: North America Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 120: North America Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 121: Canada Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 122: Canada Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 123: Mexico Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 124: Mexico Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 125: USA Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 126: USA Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 127: USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 128: South America Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 129: South America Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 130: South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 131: South America Biologics Market, 2020, By Country, Value ($ Million)
    • Figure 132: South America Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 133: South America Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 134: Argentina Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 135: Argentina Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 136: Brazil Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 137: Brazil Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 138: Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 139: Chile Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 140: Chile Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 141: Colombia Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 142: Colombia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 143: Peru Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 144: Peru Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 145: Venezuela Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 146: Venezuela Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 147: Middle East Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 148: Middle East Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 149: Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 150: Middle East Biologics Market, 2020, By Country, Value ($ Million)
    • Figure 151: Middle East Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 152: Middle East Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 153: Israel Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 154: Israel Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 155: Saudi Arabia Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 156: Saudi Arabia Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 157: Turkey Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 158: Turkey Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 159: UAE Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 160: UAE Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 161: Africa Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 162: Africa Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 163: Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 164: Africa Biologics Market, 2020, By Country, Value ($ Million)
    • Figure 165: Africa Biologics Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 166: Africa Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 167: Egypt Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 168: Egypt Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 169: Nigeria Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 170: Nigeria Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 171: South Africa Biologics Market, Historic, 2015 – 2020, $ Million
    • Figure 172: South Africa Biologics Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 173: Global Biologics Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 174: Merck & Co., Inc. – Financial Performance, 2016-2020, $ Billion
    • Figure 175: AbbVie Inc. – Financial Performance, 2016 - 2020, $ Billion
    • Figure 176: F. Hoffmann-La Roche AG – Financial Performance, 2016 – 2020, $ Billion
    • Figure 177: Johnson & Johnson – Financial Performance, 2016 – 2020, $ Billion
    • Figure 178: Pfizer Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 179: Global Pharmaceuticals Market, Segmentation By Type, 2015 – 2025, $ Billion
    • Figure 180: Global Pharmaceuticals Market, 2020, Split By Region
    • Figure 181: Global Pharmaceuticals Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
    Read More
    Global Gene Therapy Market 2022 – Market Opportunities And Strategies
    Read More
    The Microbiome Market Share, Market Size, And Growth Rate 2022
    Read More
    Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
    Read More
    CRISPR Technology Market - By Product Type (Cas9 And GRNA, Design Tools, Plasmid And Vector), By End-User (Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs), By Application (Biomedical, Agriculture, Diagnostics), And By Region, Opportunities And Strategies - Global Forecast To 2030
    View Report
    Anti-Viral Drug Therapy Market - By Drug Class (DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), Anti-Viral Drug Therapy Market Size, Opportunities And Strategies - Global Anti-Viral Drug Therapy Market Forecast To 2030
    View Report
    Anti-Viral Drug Therapy Market - By Drug Class (DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), Anti-Viral Drug Therapy Market Size, Opportunities And Strategies - Global Anti-Viral Drug Therapy Market Forecast To 2030
    View Report
    Laboratory Information System Global Market Report 2024 – By Product (Standalone LIS, Integrated LIS), By Component (Software, Services), By End User (Hospital Laboratories, Independent Laboratories, Physician Office Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    3D Diagnostic Imaging Services Global Market Report 2024 – By Technique (Ultrasound, MRI, X-ray, Computed Tomography, Other Techniques), By Application (Oncology, Cardiology, Orthopedic, Other Applications), By End User (Diagnostic Centers, Hospitals, Research Centers) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Healthcare Reimbursement Global Market Report 2024 – By Claims (Underpaid, Full Paid), By Payers (Private Payers, Public Payers), By Service Provider (Physician Office, Hospitals, Diagnostic Laboratories, Other Service Providers) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Metabolomics Global Market Report 2024 – By Product & Service (Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
    View Report
    Synthetic Biology Global Market Report 2024 – By Technology (Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering), By Product Type (Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism), By Application (Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics, Other Application) – Market Size, Trends, And Global Forecast 2024-2033
    View Report

    Frequently Asked Questions

    What is the definition of the biologics market?

    The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics or biosimilars to treat and prevent various microbial diseases and cancers. request a sample here

    How will the biologics market drivers and restraints affect biologics market dynamics? What forces will shape the biologics industry going forward?

    The biologics market growth is aided by technological advances. However, some biologics market restraints include stringent regulations related to biosimilar approvals. request a sample here

    What is the forecast market size of the biologics market?

    The biologics market forecast is expected to reach $464,604.9 million in 2023 at a compound annual growth rate of 14.7%. request a sample here

    How is the biologics market segmented?

    The global biologics market is segmented -
    By Type- The biologics market is segmented by type into
    a. Monoclonal Antibodies
    b. Therapeutic Proteins
    c. Vaccines     request a sample here

    Which region has largest share, and what is the market size and growth by geography according to the biologics global market report?

    For more detail on this, request a sample here.

    Who are the key players of the global biologics market?

    Top competitors in the biologics market are Pfizer Inc; F. Hoffmann-La Roche AG; AbbVie Inc; Merck & Co., Inc; Johnson & Johnson. request a sample here.

    What are the key trends in the global biologics market?

    Major trends influencing the biologics market include robust research & development request a sample here.

    What are the major opportunities in the biologics market and the approaches companies can take to take advantage of them?

    For this and further detailed insights on the market, request a sample here. request a sample here.

    How does the biologics market relate to the overall economy and other similar markets?

    request a sample here.

    request a sample here.

    request a sample here.